1. Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis.
- Author
-
Meijiao He, Yongtai Gong, Jing Shi, Zhenwei Pan, Hui Zou, Danghui Sun, Xin Tu, Xiangyang Tan, Jianqiang Li, Weimin Li, Bin Liu, Jingyi Xue, Li Sheng, Chunhong Xiu, Ning Yang, Hongjie Xue, Xue Ding, Chengyuan Yu, and Yue Li
- Subjects
Medicine ,Science - Abstract
OBJECTIVE: To investigate whether microRNAs (miRs) can serve as novel biomarkers for in-stent restenosis (ISR). METHODS: This retrospective, observational single-centre study was conducted at the cardiovascular department of a tertiary hospital centre in the north of China. Follow-up coronary angiography at 6 to 12 months was performed in 181 consecutive patients implanted with drug-eluting stents. Fifty-two healthy volunteers served as the control group. The plasma miRs levels were analyzed by quantitative real-time PCR. Receiver-operating characteristic curve (ROC) analysis was performed to investigate the characters of these miRs as potential biomarkers of ISR. RESULTS: MiR-21 levels in ISR patients were significantly higher than those in non-ISR patients and healthy controls (P
- Published
- 2014
- Full Text
- View/download PDF